Trial Profile
A randomised controlled study of weekly versus three weekly docetaxel in women with breast cancer
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 01 Mar 2016
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- 17 Aug 2011 New trial record